CDHD pauses Johnson & Johnson (JANSSEN) vaccine

At this time, CDHD has paused administration of Johnson and Johnson (J&J, or Janssen) vaccine per recommendation of Nebraska DHHS, the CDC and FDA. The CDC/FDA are reviewing data related to six cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. 
“People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider," the statement advises.
“We are fortunate that vaccine safety is closely monitored by healthcare providers, and our local, state, and federal partners,” Teresa Anderson stated. “This pause represents a transparent and deliberate decision to allow time for a thorough review and investigation of the J&J product. In the meantime, we will continue with our vaccination clinics.”
Central District has sufficient Pfizer and Moderna vaccine, using only Pfizer at the large clinics at the Grand Island Community Fieldhouse, and using both Pfizer and Moderna for vaccinations at the health department.
“If you were signed up or were waiting for J&J, you should consider getting either Moderna or Pfizer just because it is available now,” Anderson said. “The right vaccine is the one you can get today.”